New patent for Allergan drug RESTASIS

February 4, 2022 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for RESTASIS Restasis is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. There are ten patents protecting…

The post New patent for Allergan drug RESTASIS appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.